Our Comments on FDA’s Draft Guidance for Predetermined Change Control for AI/ML Devices
M. Jason Brooke, Esq.*
July 2, 2023
M. Jason Brooke shares his practical and legal concerns with the new draft guidance affecting AI/ML-enabled device software functions, requesting that the Agency ensures clarity and consistency with U.S. regulations and effective FDA policy.
Keep in Touch
Fill out this form to get started.
Stay in the loop with exclusive insights and valuable updates about the
medical device industry and FDA approval!